Poorly differentiated thyroid carcinoma: a clinician’s perspective

Poorly differentiated thyroid carcinoma: a clinician’s perspective

Poorly differentiated thyroid carcinoma (PDTC) is a rare thyroid carcinoma originating from follicular epithelial cells. No explicit consensus can be achieved to date due to sparse clinical data, potentially compromising the outcomes of patients. In this comprehensive review from a clinician’s persp...

Full description

Bibliographic Details
Main Authors:	Junyu Tong, Maomei Ruan, Yuchen Jin, Hao Fu, Lin Cheng, Qiong Luo, Zhiyan Liu, Zhongwei Lv, Libo Chen
Format:	Article
Language:	English
Published:	Bioscientifica 2023-01-01
Series:	European Thyroid Journal
Subjects:	poorly differentiated thyroid carcinoma pdtc
Online Access:	https://etj.bioscientifica.com/view/journals/etj/11/2/ETJ-22-0021.xml

Similar Items

Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma
by: João Roque, et al.
Published: (2023-04-01)

Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high‐grade transformation from differentiated thyroid carcinoma
by: Haiyan Gu, et al.
Published: (2024-03-01)

Poorly differentiated and undifferentiated (anaplastic) carcinoma of thyroid with diagnostic challenges: A case series
by: Arundhati Shit, et al.
Published: (2024-11-01)

Case Report: Implantation of Dedifferentiated to Poorly Differentiated Thyroid Carcinoma After Endoscopic Thyroid Surgery
by: Jin Hu, et al.
Published: (2022-05-01)

Malignant struma ovarii with thyroid-type papillary and poorly differentiated carcinoma: a case report
by: Nao Terayama, et al.
Published: (2022-09-01)

Dynamic estimates of survival of patients with poorly differentiated thyroid carcinoma: a population-based study
by: Zhao Liu, et al.
Published: (2024-09-01)

Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma
by: Omar Elghawy, et al.
Published: (2024-11-01)

A Comprehensive Review and Insights into the New Entity of Differentiated High-Grade Thyroid Carcinoma
by: Agnes Stephanie Harahap, et al.
Published: (2024-06-01)

Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature
by: Hazel Lote, et al.
Published: (2014-06-01)

Expression of T-cell immunoreceptor with immunoglobulin and tyrosine-based inhibitory motif domains (TIGIT) in anaplastic thyroid carcinoma
by: Tadao Nakazawa, et al.
Published: (2022-08-01)

Identification of super-enhancer-associated transcription factors regulating glucose metabolism in poorly differentiated thyroid carcinoma
by: Kun Liu, et al.
Published: (2022-09-01)

Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation
by: Kun Zhang, et al.
Published: (2024-03-01)

Results of treatment of patients with poorly differentiated carcinoma of the thyroid gland
by: P. A. Isaev, et al.
Published: (2023-03-01)

Poorly differentiated thyroid cancer: Clinical, pathological, mutational, and outcome analysis
by: Amit Agarwal, et al.
Published: (2024-12-01)

Immune Checkpoint Protein Expression Defines the Prognosis of Advanced Thyroid Carcinoma
by: Yi Luo, et al.
Published: (2022-04-01)

Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis
by: Shuai Jin, et al.
Published: (2022-09-01)

Synthesis, Characterization and Preliminary Anticancer Study of Novel 5-fluorouracil Conjugate with Pyrrolidine Dithiocarbamate as a Mutual Anticancer Prodrug
by: Ikram K. Shihab, et al.
Published: (2019-12-01)

Long-term efficacy and safety of fourth-line multikinase inhibitor treatment with lenvatinib in a young papillary thyroid carcinoma patient
by: S. Morelli, et al.
Published: (2017-07-01)

CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas
by: Jaime M. Pita, et al.
Published: (2023-10-01)

Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review
by: Youjin Oh, et al.
Published: (2024-01-01)

Identification of calcium metabolism related score associated with the poor outcome in papillary thyroid carcinoma
by: Chuanxiang Hu, et al.
Published: (2023-03-01)

Predictive factors and clinicopathological characteristics of outcome in poorly differentiated thyroid carcinoma: a single-institution study
by: Zheng Wan, et al.
Published: (2023-07-01)

MMP1 acts as a potential regulator of tumor progression and dedifferentiation in papillary thyroid cancer
by: Jun Zhou, et al.
Published: (2022-11-01)

Dynamic Contrast-Enhanced Computed Tomography Findings that may Predict Poorly-Differentiated Hepatocellular Carcinoma Prior to Treatment
by: Chananwat Manyanon, et al.
Published: (2020-04-01)

Comparison of New and Old Versions of Guidelines for Diagnosis and Treatment of Thyroid Nodules and Differentiated Thyroid Carcinoma in China from A Surgical Perspective
by: YANG Tingting, et al.
Published: (2024-01-01)

Post-surgical Thyroid Bed Pyoderma Gangrenosum Mimicking Recurrent Papillary Thyroid Carcinoma
by: Alessia Dolci, et al.
Published: (2019-04-01)

Evaluation of lymph node reactivity in differentiated thyroid carcinoma
by: Ali Amar, et al.
Published: (1999-05-01)

Differentiated thyroid carcinoma: what the nonspecialists needs to know
by: Ana O. Hoff, et al.
Published: (2024-06-01)

Two or three weeks of thyroid hormone withdrawal before initial 131I therapy for patients with differentiated thyroid carcinoma?
by: Yueqi Wang, et al.
Published: (2025-02-01)

Editorial: The role of genetic alterations in thyroid carcinoma
by: Joachim Feldkamp
Published: (2022-08-01)

Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes
by: Jianing Tang, et al.
Published: (2018-03-01)

COMPARATIVE MORPHOLOGICAL CHARACTERISTIC OF POORLY DIFFERENTIATED SEROUS AND ENDOMETRIOID OVARIAN CARCINOMAS
by: N.M. KHMELNITSKAYA, et al.
Published: (2017-06-01)

Consensus and controversy in postoperative thyroid stimulating hormone suppression therapy for differentiated thyroid carcinoma
by: LIU Jie, XIAN Keyao
Published: (2023-11-01)

Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma
by: Sibel Uçak Semirgin
Published: (2020-01-01)

Pandemics and thyroid neoplasia
by: Florica Sandru, et al.
Published: (2021-12-01)

Thyroid Metastasis from Breast Carcinoma Accompanied by Papillary Thyroid Carcinoma
by: Song-I Yang, et al.
Published: (2014-07-01)

Sentinel lymph node mapping: current applications and future perspectives in thyroid carcinoma
by: Isabella Merante Boschin, et al.
Published: (2023-10-01)

A Unique Case of Intranasal Metastasis from Occult Poorly Differentiated Thyroid Carcinoma
by: Rauf Oğuzhan Kum, et al.
Published: (2015-09-01)

The international approach of pediatric thyroid nodules and thyroid differentiated carcinoma. The starting point for the Romanian pediatric guideline
by: Andreea-Ioana Stefan, et al.
Published: (2021-12-01)

Identification of SUMOylation-related biomarkers in papillary thyroid carcinoma
by: Xiang Li, et al.
Published: (2024-04-01)